We are monitoring the impact of COVID-19 on Chlamydia Infection Diagnostics and Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 4949
Share on
Share on

Global Chlamydia Infection Diagnostics and Therapeutics Market Analysis - By Product Type (Diagnostics, Therapeutics), By End User (Diagnostics, Therapeutics) and By Region - Industry Size, Share, Growth, Trends, Forecast | 2019 - 2024

Pulished: August, 2019
ID: 4949
Pages: 175

Chlamydia Infection Diagnostics and Therapeutics Market Size & Growth (2019 - 2024)

The size of the Global Chlamydia Infection Diagnostics and Therapeutics Market was around USD 2.4 billion in 2019. It is expected to grow at a CAGR of 6.06% to reach USD 3.2 billion by 2024.

Chlamydia is a sexually transmitted disease. The symptoms do not occur early on. It is usually prevalent in areas with poor sanitation. It is the most common STD worldwide. Number of victims has been increasing over the last decade.

Increasing number of cases of these diseases better and complete reporting in emerging economies, augmenting screening coverage, improved funding for better R&D in this area, growing awareness regarding STDs in the developing countries along with the increased healthcare expenditures are the factors driving the growth of this market. Also accessibility to and availability of hyper sensitive diagnostic tests are also boosting the growth of this market. Furthermore, improved insurance coverage in the emerging economies augurs well for this market.

However, the stigma associated with sexually transmitted diseases is the primary restraint of market growth.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2018 – 2024

Base Year

2018

Forecast Period

2019 - 2024

Segments Covered

By Product, End User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Bio Rad laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher. Other players in the market include bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Company.

 

This research report on the Global Chlamydia Infection Diagnostics and Therapeutics Market segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.

Chlamydia Infection Diagnostics and Therapeutics Market Analysis – By Product

  • Diagnostics             
    • Nucleic Acid Amplification Tests (NAATs)
    • Direct Fluorescent Tests
    • PCR
  • Therapeutics          
    • Macrolides
    • Quinolones
    • Sulfonamides
    • Tetracycline
    • Aminopenicillins

On the basis of product, the NAAT segment is accounted for the largest market share in 2016 and is predicted to grow robustly in the forecast period. It is closely tailed by DFT in terms of CAGR. This is because NAATs are more sensitive and diagnose better. Macrolides is expected to undergo high growth in the forecast period. It also captures the largest market share and is expected to stay at the top in the forecast period.

Chlamydia Infection Diagnostics and Therapeutics Market Analysis – By End User

  • Diagnostics             
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
  • Therapeutics          

Regional Analysis:

North America is the largest regional market while Asia Pacific is expected to be the fastest growing market worldwide.

List of key market participants leading the Global Chlamydia Infection Diagnostics and Therapeutics Market profiled in this report are:

  1. Bio Rad laboratories
  2. Novartis AG
  3. F Hoffmann-La Roche
  4. Abbott Laboratories
  5. Danaher
  6. bioMerieux
  7. DiaSorin SpA
  8. Siemens AG
  9. Thermo Fisher Scientific
  10. Becton Dickinson and Company

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Product Type                            

                              5.1.1 Introduction           

                              5.1.2 Diagnostics             

                                             5.1.2.1 Nucleic Acid Amplification Tests (NAATs)

                                             5.1.2.2 Direct Fluorescent Tests

                                             5.1.2.3 PCR

                              5.1.3 Therapeutics          

                                             5.1.3.1 Macrolides

                                             5.1.3.2 Quinolones

                                             5.1.3.3 Sulfonamides

                                             5.1.3.4 Tetracycline

                                             5.1.3.5 Aminopenicillins

                              5.1.4 Y-o-Y Growth Analysis, By Product Type     

                              5.1.5 Market Attractiveness Analysis, By Product Type    

                              5.1.6 Market Share Analysis, By Product Type     

               5.2 End User                     

                              5.2.1 Introduction           

                              5.2.2 Diagnostics             

                                             5.2.2.1 Hospitals

                                             5.2.2.2 Specialty Clinics

                                             5.2.2.3 Diagnostic Centers

                              5.2.3 Therapeutics          

                                             5.2.3.1 Hospital Pharmacies

                                             5.2.3.2 Drugstores

                                             5.2.3.3 Retail Pharmacies

                                             5.2.3.4 Online Pharmacies

                              5.2.4 Y-o-Y Growth Analysis, By End User             

                              5.2.5 Market Attractiveness Analysis, By End User            

                              5.2.6 Market Share Analysis, By End User             

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Product Type

                                             6.1.3.3 By End User

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Product Type

                                             6.1.4.3 By End User

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Product Type

                                             6.1.5.3 By End User

               6.2 North America                         

                              6.1.1 Introduction           

                              6.1.2 United States         

                              6.1.3 Canada     

               6.3 Europe                        

                              6.2.1 Introduction           

                              6.2.2 U.K            

                              6.2.3 Spain         

                              6.2.4 Germany  

                              6.2.5 Italy           

                              6.2.6 France      

               6.4 Asia-Pacific                

                              6.3.1 Introduction           

                              6.3.2 China        

                              6.3.3 India         

                              6.3.4 Japan        

                              6.3.5 Australia   

                              6.3.6 South Korea           

               6.5 Latin America                           

                              6.4.1 Introduction           

                              6.4.2 Brazil         

                              6.4.3 Argentina 

                              6.4.4 Mexico     

                              6.4.5 Rest of Latin America          

               6.6 Middle East & Africa              

                              6.5.1 Introduction           

                              6.5.2 Middle-East           

                              6.5.3 Africa        

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Bio Rad laboratories               

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Novartis AG               

               8.3 F Hoffmann-La Roche                           

               8.4 Abbott Laboratories               

               8.5 Danaher                      

               8.6 bioMerieux                

               8.7 DiaSorin SpA                             

               8.8 Siemens AG               

               8.9 Thermo Fisher Scientific                       

               8.10 Becton Dickinson and Company                     

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Chlamydia Infection Diagnostics and Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  2. Global Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  3. Global Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  4. Global Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  5. Global Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  6. Global Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  7. Global Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  8. North America Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  9. North America Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  10. North America Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  11. North America Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  12. North America Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  13. North America Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  14. United States Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  15. United States Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  16. Canada Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  17. Canada Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  18. Europe Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  19. Europe Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  20. Europe Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  21. Europe Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  22. Europe Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  23. Europe Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  24. U.K. Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  25. U.K. Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  26. Germany Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  27. Germany Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  28. France Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  29. France Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  30. Italy Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  31. Italy Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  32. Spain Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  33. Spain Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  34. Asia Pacific Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  35. Asia Pacific Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  36. Asia Pacific Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  37. Asia Pacific Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  38. Asia Pacific Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  39. Asia Pacific Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  40. Japan Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  41. Japan Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  42. China Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  43. China Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  44. India Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  45. India Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  46. Australia Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  47. Australia Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  48. South Korea Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  49. South Korea Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  50. Latin America Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  51. Latin America Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  52. Latin America Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  53. Latin America Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  54. Latin America Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  55. Latin America Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  56. Brazil Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  57. Brazil Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  58. Argentina Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  59. Argentina Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  60. Mexico Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  61. Mexico Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  62. Rest of Latin America Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  63. Rest of Latin America Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  64. Middle East and Africa Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  65. Middle East and Africa Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  66. Middle East and Africa Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  67. Middle East and Africa Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  68. Middle East and Africa Diagnostics Market By Region, From 2019-2024 ( USD Billion )
  69. Middle East and Africa Therapeutics Market By Region, From 2019-2024 ( USD Billion )
  70. Middle East Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  71. Middle East Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )
  72. Africa Chlamydia Infection Diagnostics and Therapeutics Market By Product Type, From 2019-2024 ( USD Billion )
  73. Africa Chlamydia Infection Diagnostics and Therapeutics Market By End User, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample